Brynn Fowler1, N Jewel Samadder1, Deanna Kepka1,2, Qian Ding3, Lisa Pappas3, Anne C Kirchhoff1,4. 1. Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. 2. College of Nursing, University of Utah, Salt Lake City, Utah. 3. Study Design and Biostatistics Center, University of Utah, Salt Lake City, Utah. 4. Department of Pediatrics, University of Utah, Salt Lake City, Utah.
Abstract
PURPOSE: Little is known about disparities in colorectal cancer (CRC) incidence and mortality by community-level factors such as metropolitan status. METHODS: This analysis utilized data from the Surveillance, Epidemiology, and End Results (SEER) program from Utah. We included patients diagnosed with CRC from 1991 to 2010. To determine whether associations existed between metropolitan/nonmetropolitan county of residence and CRC incidence, Poisson regression models were used. CRC mortality was assessed using multivariable Cox regression models. FINDINGS: CRC incidence rates did not differ between metropolitan and nonmetropolitan counties by gender (males: 46.2 per 100,000 vs 45.1 per 100,000, P = .87; females: 34.4 per 100,000 vs 36.1 per 100,000, P = .70). However, CRC incidence between the years of 2006 and 2010 in nonmetropolitan counties was significantly higher in females (metropolitan: 30.4 vs nonmetropolitan: 37.0 per 100,000, P = .002). As compared to metropolitan counties, the incidence of unstaged CRC in nonmetropolitan counties was significantly higher in both males (1.7 vs 2.8 per 100,000, P = .003) and females (1.4 vs 1.6 per 100,000, P = .002). Among patients who were diagnosed between 2006 and 2010, metropolitan counties were found to have significantly increased survival among males and females, but nonmetropolitan counties showed increased survival only for males. CONCLUSIONS: While we observed a decreasing incidence of CRC among men and women in Utah, this effect was not seen in women in nonmetropolitan areas nor among those with unstaged disease. Further studies should evaluate factors that may account for these differences. This analysis can inform interventions with a focus on women in nonmetropolitan areas.
PURPOSE: Little is known about disparities in colorectal cancer (CRC) incidence and mortality by community-level factors such as metropolitan status. METHODS: This analysis utilized data from the Surveillance, Epidemiology, and End Results (SEER) program from Utah. We included patients diagnosed with CRC from 1991 to 2010. To determine whether associations existed between metropolitan/nonmetropolitan county of residence and CRC incidence, Poisson regression models were used. CRC mortality was assessed using multivariable Cox regression models. FINDINGS: CRC incidence rates did not differ between metropolitan and nonmetropolitan counties by gender (males: 46.2 per 100,000 vs 45.1 per 100,000, P = .87; females: 34.4 per 100,000 vs 36.1 per 100,000, P = .70). However, CRC incidence between the years of 2006 and 2010 in nonmetropolitan counties was significantly higher in females (metropolitan: 30.4 vs nonmetropolitan: 37.0 per 100,000, P = .002). As compared to metropolitan counties, the incidence of unstaged CRC in nonmetropolitan counties was significantly higher in both males (1.7 vs 2.8 per 100,000, P = .003) and females (1.4 vs 1.6 per 100,000, P = .002). Among patients who were diagnosed between 2006 and 2010, metropolitan counties were found to have significantly increased survival among males and females, but nonmetropolitan counties showed increased survival only for males. CONCLUSIONS: While we observed a decreasing incidence of CRC among men and women in Utah, this effect was not seen in women in nonmetropolitan areas nor among those with unstaged disease. Further studies should evaluate factors that may account for these differences. This analysis can inform interventions with a focus on women in nonmetropolitan areas.
Authors: Steven S Coughlin; Thomas B Richards; Trevor Thompson; Barry A Miller; Juliet VanEenwyk; Marc T Goodman; Recinda L Sherman Journal: Cancer Date: 2006-09-01 Impact factor: 6.860
Authors: Terry C Davis; Connie L Arnold; Alfred Rademaker; Stacy C Bailey; Daci J Platt; Cristalyn Reynolds; Julie Esparza; Dachao Liu; Michael S Wolf Journal: J Womens Health (Larchmt) Date: 2012-04-20 Impact factor: 2.681
Authors: Douglas K Rex; David A Johnson; Joseph C Anderson; Phillip S Schoenfeld; Carol A Burke; John M Inadomi Journal: Am J Gastroenterol Date: 2009-02-24 Impact factor: 10.864
Authors: Bernard Levin; David A Lieberman; Beth McFarland; Robert A Smith; Durado Brooks; Kimberly S Andrews; Chiranjeev Dash; Francis M Giardiello; Seth Glick; Theodore R Levin; Perry Pickhardt; Douglas K Rex; Alan Thorson; Sidney J Winawer Journal: CA Cancer J Clin Date: 2008-03-05 Impact factor: 508.702
Authors: Charles R Rogers; Brenna E Blackburn; Matthew Huntington; Karen Curtin; Roland J Thorpe; Kerry Rowe; John Snyder; Vikrant Deshmukh; Michael Newman; Alison Fraser; Ken Smith; Mia Hashibe Journal: Cancer Causes Control Date: 2020-01-30 Impact factor: 2.506
Authors: Norah Alsadhan; Alaa Almaiman; Mar Pujades-Rodriguez; Cathy Brennan; Farag Shuweihdi; Sultana A Alhurishi; Robert M West Journal: BMC Med Res Methodol Date: 2022-05-19 Impact factor: 4.612
Authors: Mia Hashibe; Anne C Kirchhoff; Deanna Kepka; Jaewhan Kim; Morgan Millar; Carol Sweeney; Kimberley Herget; Marcus Monroe; N Lynn Henry; Ana-Maria Lopez; Kathi Mooney Journal: Cancer Med Date: 2018-03-13 Impact factor: 4.452